As­traZeneca builds in­to Chi­na; Eli Lil­ly hit with 483; GSK’s new col­lab­o­ra­tion 

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more.

As­traZeneca and Taizhou Na­tion­al Med­ical …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER